MSB 0.23% $1.11 mesoblast limited

Gilead vs Mesoblast, page-274

  1. 268 Posts.
    lightbulb Created with Sketch. 41
    It's possible but it sort of needs to work even with co-morbidities... The trial is for ARDS patients <3 days on a ventilator. So the quite ill but not yet absolutely critical. If it's efficacous even for a decent percentage (and not harmful to many / any) it can be approved.

    The FDA and Meosblast could always do a Phase 4 study afterwards

    Phase 4: Studies occurring after FDA has approved a drug for marketing. These including postmarket requirement and commitment studies that are required of or agreed to by the sponsor. These studies gather additional information about a drug's safety, efficacy, or optimal use.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.003(0.23%)
Mkt cap ! $1.278B
Open High Low Value Volume
$1.13 $1.16 $1.10 $5.141M 4.596M

Buyers (Bids)

No. Vol. Price($)
23 96978 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 12114 2
View Market Depth
Last trade - 13.33pm 08/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.